Empyhema

Reading File

Finding Sources

Searching PubMed

empyema thoracis management

Reading File

Finding Sources

Reading File

Finding Sources

Loading Image

Reading File

I now have all the information needed for a comprehensive answer. Let me compile it.

Empyema (Empyema Thoracis)

Definition

Empyema is a collection of frank pus (purulent fluid) within the pleural space, resulting from invasion by pyogenic bacteria, fungi, parasites, or mycobacteria. It represents the end of a spectrum that begins with a simple parapneumonic effusion and progresses through increasingly infected and loculated stages. - Sabiston Textbook of Surgery, p. 2471

Pathogenesis and Stages

The American Thoracic Society classifies empyema into three overlapping stages:

Stage	Fluid Character	WBC (cells/mm³)	LDH (IU)	pH	Bacteria
Exudative	Thin, free-flowing, elastic	<1,000	<500	>7.3	Absent
Fibrinopurulent	Purulent, inelastic, loculated	>5,000	>1,000	<7.1	Present
Organizing	Thick, rigid fibrous peel	Varies	Varies	<7.1	Varies

Mulholland and Greenfield's Surgery, p. 4359

Stage 1 - Exudative: Increased permeability of pleural membranes leads to influx of inflammatory cells and protein-rich exudate. Fluid is thin and sterile. Most patients respond to antibiotics without drainage.

Stage 2 - Fibrinopurulent: Increased procoagulant activity promotes fibrin deposition with early then extensive septations. Pleural fluid becomes viscous; LDH rises, glucose and pH fall. Macroscopically purulent fluid. Drainage is required; chest tube alone may be insufficient.

Stage 3 - Organizing: Fibroblast proliferation generates a fibrous pleural peel encasing the lung ("trapped lung"), preventing re-expansion. Decortication is required.

Fishman's Pulmonary Diseases, Table 76-6

Causes

Parapneumonic: Most common. Up to 50% of pneumonias have an associated effusion, but <5% progress to empyema.
Trauma: Penetrating thoracic injury, hemothorax superinfection
Post-surgical: Thoracotomy, pneumonectomy (bronchopleural fistula)
Esophageal rupture/perforation
Hematogenous spread from distant infection
Tuberculosis: Especially in endemic areas or HIV-infected patients

Microbiology

Organisms have shifted significantly from the preantibiotic era:

Pre-antibiotic era: Streptococcus pneumoniae predominated (64% of all empyemas)
Current era: Anaerobic bacteria in up to 75% of cases; mixed aerobic-anaerobic flora very common
Key anaerobes: Fusobacterium nucleatum, Prevotella spp., Peptostreptococcus spp., Bacteroides fragilis
Key aerobes: Streptococcus pneumoniae, S. aureus, Klebsiella pneumoniae (especially hospital-acquired)
Hospital-acquired empyemas: Higher prevalence of S. aureus and gram-negative rods

Pleural infections are associated with death or surgical intervention in >30% of patients. - Fishman's Pulmonary Diseases, p. 127

Clinical Features

Systemic: Fever, malaise, weight loss, anorexia
Respiratory: Dyspnea, pleuritic chest pain, reduced breath sounds, dullness to percussion
In children: Worsening pneumonia with tachypnea, sometimes cyanosis; abdominal pain may be present
Chronicity: Progressive debilitation if untreated; can form pleurocutaneous fistula, chest wall mass, or rib/vertebral destruction (especially TB empyema)

Diagnosis

Imaging

Chest X-ray: First-line; shows pleural effusion, may reveal loculations
Chest CT: Best modality for identifying loculations and distinguishing empyema from lung parenchymal pathology (e.g., lung abscess). Enhancing pleural rind ("split pleura sign") is characteristic.
Ultrasound: Used to guide drainage and assess echogenicity/septations; helps identify optimal access site before thoracoscopy

Pleural Fluid Analysis (Thoracentesis)

Parameter	Significance
pH <7.2	Complicated effusion requiring drainage
Glucose <30 mg/dL	Strongly suggests empyema
LDH P:S ratio >0.6	Exudate (Light's criteria)
Protein P:S ratio >0.5	Exudate (Light's criteria)
Gross pus	Diagnostic of empyema regardless of other values
Positive Gram stain/culture	Confirms infection

Fischer's Mastery of Surgery, Table 91.2

Treatment

Treatment depends on the stage, severity, and patient comorbidities. The two cornerstones are drainage and antibiotics.

1. Antibiotics

Directed by culture; empiric coverage must include anaerobes
Used in all stages; alone sufficient only in early exudative stage with small effusion

2. Drainage

Stage 1 (Exudative): Antibiotics +/- simple thoracentesis or small pigtail catheter; chest tube if larger

Stage 2 (Fibrinopurulent):

Chest tube (28-32 Fr) - may not be effective for loculated disease
Intrapleural fibrinolytics: tPA + DNase (combination) - proven in RCTs to improve drainage and reduce surgical referral. A 2024 systematic review (PMID 39182102) found surgery vs. fibrinolysis outcomes comparable in many cases
Saline irrigation via thoracostomy - useful in patients not candidates for surgery or tPA/DNase

Surgical Options:

VATS (Video-Assisted Thoracoscopic Surgery): Definitive in 85-91% of patients; creates a single cavity, removes fibropurulent membranes, allows decortication. Early VATS reduces hospital length of stay. Preferred in complex/loculated disease.
Open thoracotomy + decortication: For organized empyema with thick pleural peel; strips the fibrous rind off the lung to allow re-expansion. Remains standard for late-stage disease.
Tube removal when drainage <100-200 mL/day with resolving clinical signs

3. Special Situations

Postpneumonectomy empyema: Very challenging; no lung tissue to fill the empty thorax. Options:

Eloesser flap - creates an open chest window
Clagett procedure - open drainage with antiseptic irrigation and later closure

TB empyema: Rare; occurs late in debilitated patients; cavity rupture into pleura causes bronchopleural fistula. Untreated: pleurocutaneous fistula, rib destruction.

Risk Stratification - RAPID Score

The RAPID score predicts 3-month mortality:

Variable	Components
R - Renal function	BUN/urea
A - Age
P - Purulence
I - Infection source	Community vs. hospital
D - Dietary factors	Albumin

RAPID Category	3-Month Mortality
Low risk	3%
Medium risk	9%
High risk	31%

High-risk patients may benefit from earlier surgical intervention. - Fishman's Pulmonary Diseases

VATS in Empyema - Illustrated

VATS treatment of empyema in a child: (A) CXR with effusion, (B) CT showing loculated empyema, (C-D) VATS views of organized debris being debrided, (E) post-op CXR, (F) resolution at 1 month

Video-assisted thoracoscopic treatment of empyema: (A) CXR with effusion, (B) CT showing loculated empyema, (C-D) VATS view of organized debris with decortication, (E) post-op CXR, (F) complete resolution at 1 month. - Mulholland and Greenfield's Surgery

Key Points Summary

Empyema = pus in the pleural space; most often complicates pneumonia
Three stages: exudative → fibrinopurulent → organizing; stage determines treatment
Anaerobes now dominate (up to 75%); hospital-acquired cases have more S. aureus / gram-negatives
Diagnose with CT + pleural fluid analysis (pH <7.2, glucose <30 mg/dL, gross pus)
Treatment: antibiotics + drainage (escalate from thoracentesis → chest tube + tPA/DNase → VATS → open decortication based on stage)
Organized empyema with trapped lung requires decortication; postpneumonectomy empyema may need Eloesser flap or Clagett procedure
RAPID score identifies high-risk patients (3-month mortality up to 31%)

Recent evidence note: A 2024 systematic review (PMID 39182102) comparing surgery vs. intrapleural fibrinolysis for complicated pleural infections found no clear superiority of surgery; early VATS and combined tPA/DNase are both reasonable first-line interventions in fibrinopurulent empyema.

This is a shared conversation. Sign in to Orris to start your own chat.